Tritace 2,5 mg tablete
| Name | Tritace 2,5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-430835109 |
| Active Substance | ramipril |
| Composition | jedna tableta sadržava 2,5 mg ramiprila |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-430835109-01] 90 tableta u blisteru, u kutiji [HR-H-430835109-02] |
| Manufacturer | Delpharm Dijon, Quetigny, Francuska sanofi-Aventis S.r.l., Scoppito (L'Aquila), Italija |
| Marketing Authorisation Holder | Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
| Marketing Authorisation Date | 01.09.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/145 |
| Registration Number | 381-12-01/286-23-40 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09AA05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
